Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Mahnken

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Plos One|February 11, 2017
Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trialJill K Morris, Eric D Vidoni, David K Johnson, et al.
Cancers|March 11, 2023
First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive FunctionJamie S Myers, Adam C Parks, Jonathan D Mahnken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 11, 2025
Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN studyRiley E Kemna, Paul J Kueck, Anneka Blankenship, et al.
Plos One|July 8, 2022
Dementia risk and dynamic response to exercise: A non-randomized clinical trialEric D Vidoni, Jill K Morris, Jacqueline A Palmer, et al.
BMC Nephrology|December 29, 2018
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohortKatelyn A McKenzie, Mirelle El Ters, Vicente E Torres, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trialJeffrey M Burns, Jill K Morris, Eric D Vidoni, et al.
The Journal of Physiology|September 11, 2024
Acute exercise alters brain glucose metabolism in aging and Alzheimer's diseaseZachary D Green, Casey S John, Paul J Kueck, et al.
Function (Oxford, England)|October 18, 2021
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal MuscleJill K Morris, Colin S McCoin, Kelly N Fuller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2019
Subclinical Cognitive Impairment and Listing for Kidney TransplantationAditi Gupta, Robert N Montgomery, Victor Bedros, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Plos One|February 11, 2017
Aerobic exercise for Alzheimer's disease: A randomized controlled pilot trialJill K Morris, Eric D Vidoni, David K Johnson, et al.
Cancers|March 11, 2023
First-Line Immunotherapy with Check-Point Inhibitors: Prospective Assessment of Cognitive FunctionJamie S Myers, Adam C Parks, Jonathan D Mahnken, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 11, 2025
Acute effects of lactate infusion on metabolism, AD biomarkers, and cognition: The LEAN studyRiley E Kemna, Paul J Kueck, Anneka Blankenship, et al.
Plos One|July 8, 2022
Dementia risk and dynamic response to exercise: A non-randomized clinical trialEric D Vidoni, Jill K Morris, Jacqueline A Palmer, et al.
BMC Nephrology|December 29, 2018
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohortKatelyn A McKenzie, Mirelle El Ters, Vicente E Torres, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 26, 2025
Effects of the SGLT2 inhibitor dapagliflozin in early Alzheimer's disease: A randomized controlled trialJeffrey M Burns, Jill K Morris, Eric D Vidoni, et al.
The Journal of Physiology|September 11, 2024
Acute exercise alters brain glucose metabolism in aging and Alzheimer's diseaseZachary D Green, Casey S John, Paul J Kueck, et al.
Function (Oxford, England)|October 18, 2021
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal MuscleJill K Morris, Colin S McCoin, Kelly N Fuller, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2019
Subclinical Cognitive Impairment and Listing for Kidney TransplantationAditi Gupta, Robert N Montgomery, Victor Bedros, et al.
Kidney360|July 29, 2021
Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Shiqin Zhang, Cassandra Johnson, et al.
Pageof 14